US biosimilar pathway: New route to biosimilar biologic drugs

被引：0
|
作者：
Berks, Andrew [1 ]
机构：
[1] Nostrum Labs Inc, New York, NY 10022 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2011年 / 242卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
9-CHAL
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Biosimilar biologic drugs: a new frontier in medical care
    Geynisman, Daniel M.
    De Velasco, Guillermo
    Sewell, K. Lea
    Jacobs, Ira
    POSTGRADUATE MEDICINE, 2017, 129 (04) : 460 - 470
  • [2] US biosimilar pathway unlikely to be used
    Wiatr C.
    BioDrugs, 2011, 25 (1) : 63 - 67
  • [3] CHANGE IN PERSISTENCE BETWEEN BIOLOGIC AND BIOSIMILAR OF INFLIXIMAB IN THE US
    Bhalani, S.
    Mishra, N.
    Gaur, A.
    Kukreja, I
    Roy, A.
    Chopra, A.
    Gupta, A.
    Brooks, L.
    Sulzicki, M.
    Verma, V.
    Pandey, S.
    Field, S.
    Krebs, B.
    VALUE IN HEALTH, 2022, 25 (07) : S442 - S443
  • [4] IMPLEMENTING A BIOLOGIC SWITCH PATHWAY TO FACILITATE TRANSITION TO BIOSIMILAR
    Mastaglio, Francesca
    Robertson, Barbara
    Crake, Diane
    McConnell, Norma
    Brownlee, Nicola
    Fyall, Julie
    Groome, Max
    Todd, John
    Paterson, Jacqueline
    Mowat, Craig
    GUT, 2021, 70 : A231 - A231
  • [5] Biosimilar Drugs
    Nacak, Muradiye
    Sezer, Zafer
    Erenmemisoglu, Aydin
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2012, 3 (02) : 251 - 256
  • [6] New Biosimilar Drugs Approved for Osteoporosis
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2024, 124 (07) : 17 - 17
  • [7] Biosimilar and interchangable biologic medications
    Simonson, William
    GERIATRIC NURSING, 2016, 37 (05) : 393 - 394
  • [8] A boost for biosimilar drugs
    Hess, Glenn
    CHEMICAL & ENGINEERING NEWS, 2017, 95 (25) : 16 - 16
  • [9] Difficulties with biosimilar drugs
    Rice, M
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (15) : 2203 - 2203
  • [10] NEW BIOSIMILAR DRUGS APPROVED FOR WET AMD
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2024, 124 (09) : 16 - 16
12345